logo
Examining The Economic Case For College Mental Health

Examining The Economic Case For College Mental Health

Forbes23-06-2025
U.S. Dollar Signs
In 2021, the American Council on Education conducted a survey of college and university presidents, which indicated that student mental health was the top-rated pressing issue. Many presidents are currently tasked with balancing the need to support student mental health with demands from other campus departments, financial constraints, as well as federal and state policies. Furthermore, the rise of preventive and online services from third-party vendors might make it difficult for some administers to know what financial investments could have the greatest returns.
Daniel Eisenberg is a professor of health policy and management at UCLA and obtained a doctoral degree in economics from Stanford University. He's a principal investigator of the Healthy Minds Network (HMN) for Research on Adolescent and Young Adult Mental Health, which administers national survey studies on college student mental health. Eisenberg argued that economic evaluations of mental health services could help administrators balance their priorities, as well as highlight the financial benefits that many campus counseling centers provide. He stated, '…our research indicates that there is a fairly strong economic case for investing in student mental health.'
The Economic Benefits Of Improved Student Mental Health
A 2024 report by the Center of Collegiate Mental Health indicated that counseling centers are remarkably effective in reducing distress and suicide ideation among students with elevated risk. While protecting against suicide, and providing crisis response services on campus, avoids emotional/financial costs to families and schools, the financial impact extends to local communities. According to a 2020 report by the Substance Abuse and Mental Health Service Administration, the average cost per case for a community mobile crisis program is $1,520, including $455 related to the mobile crisis unit being on site. Many counseling centers don't rely on mobile crisis programs, meaning that these savings to their communities are significant.
Counseling services are also effective in treating non-crisis concerns and are associated with improved academic outcomes. For example, a 2005 study in the Journal of Mental Health Policy and Economics found that untreated diagnosed depression was associated with 0.49 decrease in GPA, while receiving treatment was associated with a .044 increase in GPA. Academic performance is often a high priority for administrators, but Eisenberg argued that the financial implications of this also benefits society. He said, '…the students will end up with higher levels of education and greater lifetime earnings, which are important economic benefits for them and their communities… These economic benefits are relevant for communities on local and national scales, because we are talking about a more skilled and productive workforce emerging from higher education.' Eisenberg's argument is supported by a 2019 report by the United States Federal Reserve System, which described college education as a path to higher incomes and greater economic well-being.
Another improved academic outcome associated with student mental health is university retention. According to Eisenberg, "Reducing depressive symptoms, for example, is likely to lower the likelihood that students leave college before graduating. This means that student mental health interventions can help institutions retain tuition and other enrollment-driven revenue…' Eisenberg's argument is supported be a 2024 study in the Journal of College Student Mental Health, which found that about two-thirds of counseling center clients stated that services helped them stay in school. These savings on tuition revenue extend multiple years until graduation. Furthermore, as the 2024 study indicated, the retention rate among counseling center clients was higher than the overall campus population. Thus, campus counseling centers can have a significant financial impact on the revenue of institutions.
Return On Investment Related To Student Mental Health
In 2019, Eisenberg helped create a report with the American Council on Education about investing in student mental health. This report provided a link to an online return on investment (ROI) tool that can be customized to understand the economic returns from specific mental health investments. Eisenberg stated, 'Schools can use this online calculator to generate estimates for the economic case of investing in student mental health programs at their institution."
The professor further argued that schools should invest in services with established effectiveness. A possible example is a 2025 report by Inside Higher Ed, which discussed a statewide agreement with a telehealth provider. This report argued that more information is needed to determine if this service increased the capacity of counseling centers and if the mental health of students improved over time. According to Eisenberg, knowing the effectiveness of a service is vital. He commented, 'That said, if institutions can identify mental health programs without solid evidence of effectiveness, and replace those with programs that have stronger evidence, that is likely to yield improvements in terms of student wellbeing and economic consequences.'
Campus counseling centers are uniquely effective due to their general location, established facilities, easy access to licensed mental health providers, and real-time connections with campus stakeholders. When financial concerns affect a school, administrators often consider constraining their investments. However, Eisenberg warned about negative economic consequences for reducing mental health services on campuses. He argued, 'The negative economic consequences of decreasing investments would be the exact flip side of the positive consequences.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA Suggest Walmart Recalls Frozen Shrimp After Radiation Detected At Port
FDA Suggest Walmart Recalls Frozen Shrimp After Radiation Detected At Port

Forbes

time10 minutes ago

  • Forbes

FDA Suggest Walmart Recalls Frozen Shrimp After Radiation Detected At Port

The Food and Drug Administration is warning that some Great Value brand frozen shrimp sold at Walmart could be contaminated with radioactive isotope Cesium-137 after Customs and Border Protection detected the substance in shipping containers at four major American ports and at least one sample of shrimp. Cesium-137 was detected in some frozen shrimp coming from Indonesia—but none that have been sold in stores yet. getty The FDA is investigating the potential contamination and has not 'confirmed the presence of contamination in any product in commerce,' they are still warning consumers to avoid eating shrimp that come from the same Indonesian producer BMS Foods. The FDA is recommending Walmart recall frozen shrimp coming from BMS Foods, and the retailer has not returned a request for comment from Forbes. This is a breaking story and will be updated.

Medical group goes against CDC, recommend COVID shots for young kids
Medical group goes against CDC, recommend COVID shots for young kids

Fox News

time41 minutes ago

  • Fox News

Medical group goes against CDC, recommend COVID shots for young kids

The Centers for Disease Control and Prevention (CDC) no longer recommends the COVID-19 vaccine for children — but a major medical group is going against that guidance. On Tuesday, the American Academy of Pediatrics (AAP) released its latest annual immunization schedule for children — and it includes vaccines for COVID-19, in addition to flu and RSV. "Infants and children 6 through 23 months of age are at the highest risk for severe COVID-19," the AAP states in its release. "Given this, the AAP recommends a COVID-19 vaccine for all children ages 6 through 23 months old to help protect against serious illness." The AAP also recommends a "single dose of age-appropriate COVID-19 vaccine" for kids and teens 2 and older who are at high risk of severe COVID, have never been vaccinated before, and who live with people who are at a high risk of severe disease. "The AAP also recommends the vaccine be available for children aged 2-18 who do not fall into these risk groups, but whose parent or guardian desires them to have the protection of the vaccine," the release states. "Among the reasons we decided to move to a risk-based recommendation for healthy older children is the fact that the hospitalization rate for young children and children with underlying medical conditions remains high, in line with rates for many of the other vaccine-preventable diseases for which we vaccinate," said Sean O'Leary, M.D., chair of the AAP Committee on Infectious Diseases, in the release. In May 2025, HHS Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines would be removed from the CDC's routine immunization schedule for healthy children and pregnant women. Instead of a universal recommendation, the CDC's updated guidance calls for "shared clinical decision-making," in which parents and doctors discuss the benefits and risks of vaccination for each individual case. "Where the parent presents with a desire for their child to be vaccinated, children 6 months and older may receive COVID-19 vaccination, informed by the clinical judgment of a healthcare provider and personal preference and circumstances," the CDC's guidance states. In total, the AAP's schedule includes immunizations against 18 diseases, recommended for all children from birth to age 18. The AAP noted in a press release that its vaccine schedule "differs from recent recommendations of the Advisory Committee on Immunization Practices of the CDC." For more Health articles, visit Other included updates involve the pentavalent meningococcal vaccine, the starting age of the human papilloma virus vaccine, and removal of a hepatitis vaccine that is no longer available, the release states.

Walmart's Great Value shrimp has risk of radioactive contamination, FDA says. Here are the details.
Walmart's Great Value shrimp has risk of radioactive contamination, FDA says. Here are the details.

CBS News

time41 minutes ago

  • CBS News

Walmart's Great Value shrimp has risk of radioactive contamination, FDA says. Here are the details.

Some frozen shrimp sold at Walmart under the Great Value label are at risk of radioactive contamination and shouldn't be consumed, according to a warning from the U.S. Food and Drug Administration. The frozen shrimp were imported from Indonesian company PT. Bahari Makmur Sejati and sold at Walmart stores as Great Value brand frozen raw shrimp, the FDA said on Tuesday. The agency noted it has recommended that Walmart recall the product. Walmart didn't immediately respond to a request for comment. The shrimp could be contaminated with a radioactive isotope called Cesium-137, although the FDA said that no products as of yet have tested positive for it. The agency said it issued the warning about Walmart's Great Value shrimp after it had detected Cesium-137 in a single shipment of frozen shrimp from PT. Bahari Makmur Sejati. That shipment "did not enter U.S. commerce," the FDA said. Here's what to know about the warning. The FDA said that consumers "should not eat or serve certain lots of Great Value raw frozen shrimp from Walmart." The lots are: Consumers who bought the shrimp cited in the FDA's notice should throw it away, the agency said. "Distributors and retailers should dispose of this product and should not sell or serve this product," the FDA added. Cesium-137, or Cs-137, is the radioactive form of the element cesium, according to the U.S. Environmental Protection Agency. Produced by nuclear fission, it's used in medical devices and is also a byproduct of nuclear fission in nuclear reactors and weapons testing, the EPA notes. The Cesium-137 detected in the imported shrimp was about 68 Bq/kg, which the FDA said sits below its threshold of 1200 Bq/kg for "levels of concern" for imported foods. "At this level, the product would not pose an acute hazard to consumers," the FDA said in its warning notice. However, the FDA noted that repeated low-dose exposure to Cesium-137 carries an "elevated risk of cancer, resulting from damage to DNA within living cells of the body." It added, "Avoiding products like the shipment FDA tested with similar levels of Cs-137 is a measure intended to reduce exposure to low-level radiation that could have health impacts with continued exposure over a long period of time."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store